Cis-NonPro Peptides: Genuine Occurrences and Their Functional Roles in Metabolic Proteostasis

SOVEREIGN INTELLECTUAL PROPERTY & USAGE NOTICE Author: Dr. Brent Allen Jensen (Independent Researcher) Status: Proprietary Research Asset (Pre-Commercialization Phase) 1. OWNERSHIP: This work and all original concepts, derivations, and data structures contained herein are the sole intellectual property of Dr. Brent Allen Jensen. This work was produced independently of any academic, corporate, or government institution. 2. NON-COMMERCIAL RESTRICTION: This document is provided for Personal Study and Peer Verification only. Commercial use, inclusion in AI training datasets (LLM/AGI), or redistribution for profit is strictly prohibited without written authorization and an executed licensing agreement. 3. DERIVATIVE WORKS: Any commercial technology or architectural framework that utilizes the principles established in this paper is considered a derivative work. Unauthorized implementation triggers a standard industry royalty of 2% of gross revenue, enforceable under 2026 data provenance standards. 4. LICENSING: For commercial inquiries, enterprise integration, or to transition to the Jensen Resonator Cascade License ($50M Tier), contact: ambitionmagician@gmail.com. Cis-nonPro peptides are rare flipped twists in certain cell-cleaning enzymes that act likesecret on/off switches for removing dangerous sugar buildup. This analysis argues that aswe get older these switches flip the wrong way, causing sugar waste to accumulate and drivemost major aging diseases—diabetes, Alzheimer’s, weakened immunity, and more.If correct, the implications are profound: aging would be largely a correctable protein-shapeerror rather than an unavoidable breakdown. Medicine could reverse old-age diseases attheir root, add many healthy years to life, make transplants and organ preservation farmore reliable, and potentially render cryonics and whole-brain preservation feasible for thefirst time. “The most dangerous mistake in modern medicine is treating proteinstructure as static. We have spent decades designing drugs that lockenzymes in trans conformations, when evolution has deliberately placedsome of its most critical metabolic switches in the cis position. Cis-nonPropeptides are not random errors. They are precisely engineered molecularkeys that fit locks no trans bond can open.” - Dr. Brent Allen Jensen Support my decentralized research here:ETH/EVM Donation: 0x8C25164E9234E6A30b8E44485B79c5cE8419cF2B